RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Gertraud Maskarinec to Soy Foods

This is a "connection" page, showing publications Gertraud Maskarinec has written about Soy Foods.
Connection Strength

6.418
  1. Maskarinec G, Ju D, Morimoto Y, Franke AA, Stanczyk FZ. Soy Food Intake and Biomarkers of Breast Cancer Risk: Possible Difference in Asian Women? Nutr Cancer. 2017 01; 69(1):146-153.
    View in: PubMed
    Score: 0.549
  2. Maskarinec G, Suzuki S, Pagano IS, Morimoto Y, Franke AA, Ehya H. Cytology in nipple aspirate fluid during a randomized soy food intervention among premenopausal women. Nutr Cancer. 2013; 65(8):1116-21.
    View in: PubMed
    Score: 0.442
  3. Harmon BE, Morimoto Y, Beckford F, Franke AA, Stanczyk FZ, Maskarinec G. Oestrogen levels in serum and urine of premenopausal women eating low and high amounts of meat. Public Health Nutr. 2014 Sep; 17(9):2087-93.
    View in: PubMed
    Score: 0.440
  4. Messina M, Caan BJ, Abrams DI, Hardy M, Maskarinec G. It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Oncology (Williston Park). 2013 May; 27(5):430-7.
    View in: PubMed
    Score: 0.428
  5. Maskarinec G, Morimoto Y, Heak S, Isaki M, Steinbrecher A, Custer L, Franke AA. Urinary estrogen metabolites in two soy trials with premenopausal women. Eur J Clin Nutr. 2012 Sep; 66(9):1044-9.
    View in: PubMed
    Score: 0.403
  6. Sen C, Morimoto Y, Heak S, Cooney RV, Franke AA, Maskarinec G. Soy foods and urinary isoprostanes: results from a randomized study in premenopausal women. Food Funct. 2012 May; 3(5):517-21.
    View in: PubMed
    Score: 0.394
  7. Morimoto Y, Conroy SM, Pagano IS, Isaki M, Franke AA, Nordt FJ, Maskarinec G. Urinary estrogen metabolites during a randomized soy trial. Nutr Cancer. 2012; 64(2):307-14.
    View in: PubMed
    Score: 0.393
  8. Maskarinec G, Ollberding NJ, Conroy SM, Morimoto Y, Pagano IS, Franke AA, Gentzschein E, Stanczyk FZ. Estrogen levels in nipple aspirate fluid and serum during a randomized soy trial. Cancer Epidemiol Biomarkers Prev. 2011 Sep; 20(9):1815-21.
    View in: PubMed
    Score: 0.377
  9. Maskarinec G, Morimoto Y, Conroy SM, Pagano IS, Franke AA. The volume of nipple aspirate fluid is not affected by 6 months of treatment with soy foods in premenopausal women. J Nutr. 2011 Apr 01; 141(4):626-30.
    View in: PubMed
    Score: 0.367
  10. Morimoto Y, Steinbrecher A, Kolonel LN, Maskarinec G. Soy consumption is not protective against diabetes in Hawaii: the Multiethnic Cohort. Eur J Clin Nutr. 2011 Feb; 65(2):279-82.
    View in: PubMed
    Score: 0.358
  11. Maskarinec G, Erber E, Verheus M, Hernandez BY, Killeen J, Cashin S, Cline JM. Soy consumption and histopathologic markers in breast tissue using tissue microarrays. Nutr Cancer. 2009; 61(5):708-16.
    View in: PubMed
    Score: 0.317
  12. Maskarinec G, Watts K, Kagihara J, Hebshi SM, Franke AA. Urinary isoflavonoid excretion is similar after consuming soya milk and miso soup in Japanese-American women. Br J Nutr. 2008 Aug; 100(2):424-9.
    View in: PubMed
    Score: 0.298
  13. Maskarinec G, Hebshi S, Custer L, Franke AA. The relation of soy intake and isoflavone levels in nipple aspirate fluid. Eur J Cancer Prev. 2008 Feb; 17(1):67-70.
    View in: PubMed
    Score: 0.298
  14. Franke AA, Morimoto Y, Yeh LM, Maskarinec G. Urinary isoflavonoids as a dietary compliance measure among premenopausal women. Asia Pac J Clin Nutr. 2006; 15(1):88-94.
    View in: PubMed
    Score: 0.258
  15. Maskarinec G. Soy foods for breast cancer survivors and women at high risk for breast cancer? J Am Diet Assoc. 2005 Oct; 105(10):1524-8.
    View in: PubMed
    Score: 0.253
  16. Maskarinec G, Morimoto Y, Novotny R, Nordt FJ, Stanczyk FZ, Franke AA. Urinary sex steroid excretion levels during a soy intervention among young girls: a pilot study. Nutr Cancer. 2005; 52(1):22-8.
    View in: PubMed
    Score: 0.240
  17. Maskarinec G, Takata Y, Franke AA, Williams AE, Murphy SP. A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr. 2004 Nov; 134(11):3089-94.
    View in: PubMed
    Score: 0.238
  18. Conroy SM, Maskarinec G, Park SY, Wilkens LR, Henderson BE, Kolonel LN. The effects of soy consumption before diagnosis on breast cancer survival: the Multiethnic Cohort Study. Nutr Cancer. 2013; 65(4):527-37.
    View in: PubMed
    Score: 0.105
  19. Maskarinec G. The human mammary gland as a target for isoflavones: how does the relation vary in individuals with different ethnicity? Planta Med. 2013 May; 79(7):554-61.
    View in: PubMed
    Score: 0.104
  20. Takata Y, Maskarinec G, Rinaldi S, Kaaks R, Nagata C. Serum insulin-like growth factor-I levels among women in Hawaii and Japan with different levels of tofu intake. Nutr Cancer. 2006; 56(2):136-42.
    View in: PubMed
    Score: 0.064
  21. Maskarinec G, Takata Y, Murphy SP, Franke AA, Kaaks R. Insulin-like growth factor-1 and binding protein-3 in a 2-year soya intervention among premenopausal women. Br J Nutr. 2005 Sep; 94(3):362-7.
    View in: PubMed
    Score: 0.063
  22. Morimoto Y, Maskarinec G, Park SY, Ettienne R, Matsuno RK, Long C, Steffen AD, Henderson BE, Kolonel LN, Le Marchand L, Wilkens LR. Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort. Br J Nutr. 2014 Sep 28; 112(6):976-83.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support